A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial

Blauvelt A, Papp K, Gottlieb A, Jarell A, Reich K, Maari C, Gordon KB, Ferris LK, Langley RG, Tada Y, Lima RG, Elmaraghy H, Gallo G, Renda L, Park SY, Burge R, Bagel J, IXORA-R Study Group; Jill Waibel

A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial

Blauvelt A, Papp K, Gottlieb A, Jarell A, Reich K, Maari C, Gordon KB, Ferris LK, Langley RG, Tada Y, Lima RG, Elmaraghy H, Gallo G, Renda L, Park SY, Burge R, Bagel J, IXORA-R Study Group, Jill Waibel

Baptist Health South Florida

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	The British journal of dermatology
Volume	[Epub ahead of print]
State	Published - 2019

Disciplines

Medicine and Health Sciences

Cite this

IXORA-R Study Group, B. A. P. K. G. A. J. A. R. K. M. C. G. KB. F. LK. L. RG. T. Y. L. RG. E. H. G. G. R. L. P. SY. B. R. B. J., & Waibel, J. (2019). A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial. The British journal of dermatology, [Epub ahead of print].

A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial. / IXORA-R Study Group, Blauvelt A, Papp K, Gottlieb A, Jarell A, Reich K, Maari C, Gordon KB, Ferris LK, Langley RG, Tada Y, Lima RG, Elmaraghy H, Gallo G, Renda L, Park SY, Burge R, Bagel J,; Waibel, Jill.
In: The British journal of dermatology, Vol. [Epub ahead of print], 2019.

Research output: Contribution to journal › Article › peer-review

IXORA-R Study Group, Blauvelt A, Papp K, Gottlieb A, Jarell A, Reich K, Maari C, Gordon KB, Ferris LK, Langley RG, Tada Y, Lima RG, Elmaraghy H, Gallo G, Renda L, Park SY, Burge R, Bagel J, ; Waibel, Jill. / A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial. In: The British journal of dermatology. 2019 ; Vol. [Epub ahead of print].

@article{7c209b28520841e68233320a740508ec,

title = "A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial",

author = "\{IXORA-R Study Group\}, \{Blauvelt A, Papp K, Gottlieb A, Jarell A, Reich K, Maari C, Gordon KB, Ferris LK, Langley RG, Tada Y, Lima RG, Elmaraghy H, Gallo G, Renda L, Park SY, Burge R, Bagel J,\} and Jill Waibel",

note = "Br J Dermatol. 2019 Dec 30. doi: 10.1111/bjd.18851. [Epub ahead of print]",

year = "2019",

language = "American English",

volume = "[Epub ahead of print]",

journal = "The British journal of dermatology",

}

TY - JOUR

T1 - A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial

AU - IXORA-R Study Group, Blauvelt A, Papp K, Gottlieb A, Jarell A, Reich K, Maari C, Gordon KB, Ferris LK, Langley RG, Tada Y, Lima RG, Elmaraghy H, Gallo G, Renda L, Park SY, Burge R, Bagel J,

AU - Waibel, Jill

N1 - Br J Dermatol. 2019 Dec 30. doi: 10.1111/bjd.18851. [Epub ahead of print]

PY - 2019

Y1 - 2019

UR - https://www.ncbi.nlm.nih.gov/pubmed/31887225

M3 - Article

VL - [Epub ahead of print]

JO - The British journal of dermatology

JF - The British journal of dermatology

ER -

A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial

Disciplines

Other files and links

Cite this